Proactive Investors - Run By Investors For Investors

Amazon now carrying NovaBay Pharmaceuticals’ Avenova eye-care product; shares skyrocket

Avenova is available without a prescription on Amazon's new direct direct-to-consumer online channel
eye
The Avenova spray removes bacteria and debris on and around the eyelid that contribute to bacterial eye infections

Shares of NovaBay Pharmaceuticals Inc (NYSEAMERICAN:NBY) increased more than six-fold Monday after the company announced that its Avenova eye-care product is now available without a prescription at Amazon.com.

The Emeryville, California-based biopharmaceutical company said customers can purchase Avenova on Amazon.com Inc's (NASDAQ:AMZN) new direct direct-to-consumer online channel.

NovaBay’s stock exploded 541% to $2.04 a share on heavy volume Monday afternoon. 

Treating dry eyes

Avenova, a spray, is designed for the removal of bacteria and debris on and around the eyelid margin that contribute to bacterial eye infections, which represent approximately 85% of the dry eye market, the company said.

“While prescription Avenova continues to be available through retail pharmacies and direct in-office sales by certain eye-care specialists, patients and physicians have asked for greater accessibility to the product," said CEO Justin Hall. "In response, we are launching our new US direct-to-consumer channel, which is a significant step in ensuring easy access at an affordable price."

Avenova, or Avenova Direct as the online version is called, is available from Amazon in the US in a 20 milliliter size for $29.99, the company said.

-- updates stock price --- 

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

View full NBY profile View Profile

NovaBay Pharmaceuticals Timeline

Related Articles

human kidneys
May 06 2019
The Danish company is seeking FDA approval of the test for use in both adults and children
A paper rocket is ready to launch on a surgeon's scissors
March 28 2019
The company hopes to improve its share price with ADAPT technology successes.
seeds in a bowl
March 07 2019
The Vancouver company is developing Omega-3 products as oil, powder or emulsion to be used as food additives

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use